New patent expiration for Eli Lilly drug AXIRON

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for AXIRON
Annual Drug Patent Expirations for AXIRON

Axiron is a drug marketed by Eli Lilly And Co and is included in one NDA. There are seven patents protecting this drug and one Paragraph IV challenge.

AXIRON drug price trends.

Drug patent litigation for AXIRON.

This drug has fifty-five patent family members in fifteen countries.

The generic ingredient in AXIRON is testosterone. Additional details are available on the testosterone profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top